08:43 AM EST, 11/26/2024 (MT Newswires) -- PharmaTher Holdings ( PHRRF ) on Tuesday said it will cancel its meeting with the U.S. Food and Drug Administration after the regulator responded to its questions that were in the post-complete response letter clarification meeting scheduled for Dec. 2.

The responses were satisfactory and do not require further discussion, the company said. PharmaTher ( PHRRF ) said it will resubmit information to address the deficiencies classified as MINOR in the complete response letter by January.